Acellular Tissue Engineered Vessels (ATEV)

ONY Biotech is partnering with a start-up company formed by faculty in Chemical and Bioengineering at the University at Buffalo to develop acellular tissue engineered vessels (ATEV). Once implanted, the ATEV evolves over a few weeks into an anatomically and physiologically normal blood vessel populated by the recipient’s own cells. This technology may offer new options for vascular anomalies and diseases.